ValiRx plc

VAL.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-£945-£971-£1,002
Dep. & Amort.£133£134£136
Deferred Tax£0£0£0
Stock-Based Comp.£0£0£0
Change in WC£98£15£134
Other Non-Cash£13-£62£282
Operating Cash Flow-£701-£884-£668
Investing Activities
PP&E Inv.-£10-£28-£3
Net Acquisitions£0£0£0
Inv. Purchases£30-£30£0
Inv. Sales/Matur.£0£0£0
Other Inv. Act.£0£0£0
Investing Cash Flow£20-£58-£3
Financing Activities
Debt Repay.-£5-£5-£5
Stock Issued£1,433£1,582-£39
Stock Repurch.£0£0£0
Dividends Paid£0£0£0
Other Fin. Act.£0£0-£2
Financing Cash Flow£1,428£1,577-£46
Forex Effect£0£0£0
Net Chg. in Cash£747£634-£717
Supplemental Information
Beg. Cash£809£175£891
End Cash£1,556£809£175
Free Cash Flow-£711-£912-£671
ValiRx plc (VAL.L) Financial Statements & Key Stats | AlphaPilot